Not finding it? Sign in to also search OpenAlex live.
-
163 Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesions2022 Regular and Young Investigator Award Abstracts conference-abstract Medicine Cervical Cancer and HPV Research Open access
Ziena Abdulrahman, Natasja Hendriks, Arnold‐Jan Kruse, Antonios Somarakis, Anna J. M. van de Sande, Heleen J. van Beekhuizen, +7 more
0citations -
356 Personalized immunotherapy by adoptive T cell transfer during chemotherapy with or without interferon-alpha in patients with recurrent platinum-sensitive epithelial ovarian cancer2021 Regular and Young Investigator Award Abstracts conference-abstract Medicine Ovarian cancer diagnosis and treatment Open access
Els M.E. Verdegaal, Marten Visser, Lien van der Minne, Linda de Bruin, Inge C.F.M. Roozen, Pauline Meij, +2 more
0citations -
962 Single-cell spatial in situ transcriptomics unravels vulvar HSIL composition associated with complete response to therapeutic vaccination2023 Regular and Young Investigator Award Abstracts conference-abstract Medicine Cervical Cancer and HPV Research Open access
Ziena Abdulrahman, Mariëtte I.E. van Poelgeest, Marij J.P. Welters, Sjoerd van der Burg
0citations -
161 Single-cell spatial in situ transcriptomics unravels vulvar HSIL composition associated with complete response to therapeutic vaccination2022 Regular and Young Investigator Award Abstracts conference-abstract Medicine Cervical Cancer and HPV Research Open access
Ziena Abdulrahman, Mariette I. van Poelgeest, Marij JP Welters, Sjoerd H. van der Burg
0citations -
A prediction model for response to immune checkpoint inhibition in advanced melanoma.2023 Journal of Clinical Oncology conference-abstract Medicine Cancer Immunotherapy and Biomarkers Open access
Isabella A.J. van Duin, Rik Jasper Verheijden, P. J. van Diest, Alfonsus Johannes Maria van den Eertwegh, Jan Willem de Groot, Olivier Jules van Not, +14 more
0citations -
Blood based kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage non-small cell lung cancer: The IOpener study.2024 Journal of Clinical Oncology conference-abstract Medicine Cancer Immunotherapy and Biomarkers Open access
Karlijn de Joode, Harry J.M. Groen, Michel M. van den Heuvel, Jeroen S. Kloover, Femke S. van der Meer, Cor H. van der Leest, +12 more
0citations -
First safety and efficacy results of PRADO: A phase II study of personalized response-driven surgery and adjuvant therapy after neoadjuvant ipilimumab (IPI) and nivolumab (NIVO) in resectable stage III melanoma.2020 Journal of Clinical Oncology conference-abstract Medicine Cutaneous Melanoma Detection and Management
Christian U. Blank, Irene L. M. Reijers, Thomas E. Pennington, Judith M. Versluis, Robyn P.M. Saw, Elisa A. Rozeman, +14 more
62citations -
Combination of vemurafenib with cobimetinib in BRAF V600E/K mutated melanoma patients to normalize LDH and optimize immunotherapy with nivolumab and ipilimumab (COWBOY): A randomized, open-label phase 2 clinical trial.2026 Journal of Clinical Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Melanoma and MAPK Pathways
Anne Sophie Blokland, Rutger H.T. Koornstra, Sofie H. Tolmeijer, Hans M. Westgeest, Marye J. Boers‐Sonderen, Ellen Kapiteijn, +12 more
0citations -
Survival data of PRADO: A phase 2 study of personalized response-driven surgery and adjuvant therapy after neoadjuvant ipilimumab (IPI) and nivolumab (NIVO) in resectable stage III melanoma.2022 Journal of Clinical Oncology conference-abstract Medicine Cutaneous Melanoma Detection and Management
Christian U. Blank, Irene L. M. Reijers, Robyn P.M. Saw, Judith M. Versluis, Thomas E. Pennington, Ellen Kapiteijn, +14 more
17citations -
The impact of emotional distress on pathologic response and survival after neoadjuvant combination immune checkpoint blockade (ICB) in high-risk stage III melanoma.2023 Journal of Clinical Oncology conference-abstract Medicine Cancer Immunotherapy and Biomarkers Open access
Irene L. M. Reijers, Itske Fraterman, Petros Dimitriadis, Annegien Broeks, Maria Gonzalez, Alexander Maxwell Menzies, +7 more
3citations -
AI-detected tumor-infiltrating lymphocytes and response to PD-1 based treatment in advanced melanoma.2025 Journal of Clinical Oncology conference-abstract Medicine Cancer Immunotherapy and Biomarkers Open access
Mark Schuiveling, Isabella A.J. van Duin, Janneke C. van der Weerd, Franchette van den Berkmortel, Femke H. Burgers, Marye J. Boers‐Sonderen, +13 more
1citations -
88 Genetic association between vitiligo genetic susceptibility and response to immune-checkpoint inhibitortherapy in advanced melanoma patients2022 Regular and Young Investigator Award Abstracts conference-abstract Medicine Cancer Immunotherapy and Biomarkers Open access
Wouter Ouwerkerk, Saskia Chielie, Marcel W. Bekkenk, Remco van Doorn, Christian U. Blank, John B.A.G. Haanen, +9 more
0citations -
Neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in macroscopic, resectable stage III melanoma: The phase 3 NADINA trial.2024 Journal of Clinical Oncology conference-abstract Medicine Cutaneous Melanoma Detection and Management Open access
Christian U. Blank, Minke W. Lucas, Richard A. Scolyer, Bart A. van de Wiel, Alexander Maxwell Menzies, Marta López‐Yurda, +14 more
27citations